Protagonist Therapeutics Inc Free Cash Flow Generation Index

Latest as of March 2025: 1.00x

Protagonist Therapeutics Inc free cash flow generation index. Protagonist Therapeutics Inc (PTGX) has a Free Cash Flow Generation Index of 1.00x as of March 2025. Free cash flow of $124.82 Million represents 1% of operating cash flow ($125.36 Million).

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$124.82 Million
USD

Operating Cash Flow

$125.36 Million
USD

Capital Expenditures

$545.00K
USD

Free Cash Flow Generation Index of Protagonist Therapeutics Inc (2017–2024)

Free cash flow generation index of Protagonist Therapeutics Inc from 2017 to 2024. Historical FCF Generation Index trend for Protagonist Therapeutics Inc across 2 annual periods. See Protagonist Therapeutics Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Protagonist Therapeutics Inc Free Cash Flow Generation Index by Year (2017–2024)

Protagonist Therapeutics Inc free cash flow generation index by year from 2017 to 2024. Year-by-year Free Cash Flow Generation Index for Protagonist Therapeutics Inc. For the full cash flow conversion analysis, see Protagonist Therapeutics Inc cash conversion from operations.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2024 0.99x $182.80 Million $184.15 Million $1.35 Million ▲ +19.9%
2017 0.83x $3.21 Million $3.87 Million $666.00K —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).